Malignant neoplasm of urinary bladder
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
2113
|
316
|
0.080 |
None |
1.000 |
8 |
|
2005 |
2017 |
Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.070 |
None |
1.000 |
7 |
|
2005 |
2019 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.020 |
None |
0.500 |
2 |
|
2005 |
2011 |
Mucopolysaccharidoses
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
48
|
7
|
0.020 |
None |
1.000 |
2 |
|
2005 |
2017 |
Mucopolysaccharidosis IV
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
28
|
9
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Endometrial Carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
1597
|
326
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Metastatic Prostate Carcinoma
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
362
|
24
|
0.010 |
None |
1.000 |
1 |
|
2006 |
2006 |
Prostatic Neoplasms
|
group |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
1722
|
31
|
0.020 |
None |
1.000 |
2 |
|
2007 |
2019 |
Invasive Prostate Carcinoma
|
disease |
|
Neoplastic Process
|
45
|
|
0.010 |
None |
1.000 |
1 |
|
2007 |
2007 |
Mammary Neoplasms
|
group |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
2780
|
385
|
0.020 |
None |
0.500 |
2 |
|
2008 |
2016 |
Degenerative polyarthritis
|
disease |
Musculoskeletal Diseases
|
Disease or Syndrome
|
1827
|
247
|
0.020 |
None |
1.000 |
2 |
|
2008 |
2017 |
Squamous cell carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2507
|
257
|
0.020 |
None |
1.000 |
2 |
|
2008 |
2019 |
Lysosomal Storage Diseases
|
group |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
130
|
8
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Lung Neoplasms
|
group |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
1486
|
39
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Pulmonary Hypertension
|
phenotype |
Respiratory Tract Diseases
|
Pathologic Function
|
156
|
|
0.200 |
None |
1.000 |
1 |
|
2010 |
2010 |
Neoplasm Metastasis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6385
|
327
|
0.070 |
None |
0.857 |
7 |
|
2011 |
2019 |
Juvenile arthritis
|
disease |
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases
|
Disease or Syndrome
|
450
|
128
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Familial (FPAH)
|
disease |
|
Disease or Syndrome
|
1075
|
276
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Juvenile rheumatoid arthritis
|
disease |
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases
|
Disease or Syndrome
|
183
|
10
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Carcinoma, Ovarian Epithelial
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
2841
|
327
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Epithelial ovarian cancer
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
1224
|
129
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Tumor Progression
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Neoplastic Process
|
3865
|
72
|
0.010 |
None |
< 0.001 |
1 |
|
2011 |
2011 |
Carcinoma
|
group |
Neoplasms
|
Neoplastic Process
|
2462
|
103
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Allergic sensitization
|
disease |
|
Disease or Syndrome
|
85
|
26
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Nasal Polyps
|
disease |
Pathological Conditions, Signs and Symptoms; Respiratory Tract Diseases; Otorhinolaryngologic Diseases
|
Disease or Syndrome
|
484
|
34
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |